NMNAT1 and proteostasis deficiencies: Recently, high-throughput screens have identified small molecules to boost Nmnat expression in neurons or enhance NAD+ production (Ali et al., 2017; Gardell et al., 2019), highlighting the therapeutic potential of targeting Nmnat/NAD+ in treating AD and other proteinopathies.